(CNN)In a rare move, the companies that make the multiple sclerosis drug daclizumab (brand name Zinbryta) have voluntarily pulled the medication from the market and stopped all clinical studies after reports of eight cases of serious brain inflammation among patients in Europe
Read the full article here:
Each one of the drugs we take to keep as well, has side effects. You have to weigh the odds, the pros and cons of each of these medicines. I’ve been taking these medicines for 20 years. I started with Betaseron. I had a few intervals with Rebif and Copaxone. I moved to Gilenya in 2011. Unfortunately as my disease progressed I had to move to to Tysabri, up to Rituxan and now I’m on Ocrevus. You can see from my history my drugs got stronger as I became worse. The stronger the medicine the more serious the side effects. Talk to your doctor and do your research and make the best decision for YOU. That is the best advice I can give.